Introduction. This review is related to the mechanism of development of
radiation induced pneumonitis, its pathological, clinical and radiological
features and therapy. The team treating cancer patients consists of radiation
oncologists and oncologists, as well as general practitioners, pulmologists
and radiologists for monitoring effects of therapy. Therefore, a different
number of specialists should be familiar with the importance of diagnosis in
order to avoid differential diagnostic error in relation to infection,
relapse or metastasis, chemotherapeutic adverse effects. Lung damage by
ionizing radiation. Factors that influence the development of radiation
pneumonitis are numerous: (1) the volume of irradiated parenchyma (2) the
absorbed dose, (3) the number of fractions which divided the absorbed dose,
(4) the size of individual doses per fraction, (5) radiation dose rate (the
radiotherapy output device). Acute radioneumonitis is characterized by
dyspnea, cough, and, rarely, fever and chest pain. The timely treatment of
the symptoms makes it easier for patients and reduces the likelihood of
developing pulmonary fibrosis. Diagnosis of radiation pneumonitis. There are
no specific markers in serum or sputum that would definitely indicate the
development of acute pneumonitis. Changes in lung radiography and computed
tomography may suggest its development; however, extra diagnostics
information sometime needs to be obtained from magnetic resonance images and
positron emission tomography to make diagnosis and choose the treatment.
Conclusion. The longer survival results from new modalities of treatment
applied in cancer patients, and the prevention of adverse effects of
radiation therapy is getting more important since longlasting toxicity
affects the life quality.